The Comparison of Postoperative Pain After Colon Resection in Intravenous Patient-controlled Analgesia Between Conventional Mode and Optimizing B.I Mode With 'PAINSTOP' Equipment
Primary Purpose
Colon Cancer
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Optimizing B.I (New) PCA mode
Conventional PCA mode
Sponsored by

About this trial
This is an interventional other trial for Colon Cancer focused on measuring Colon resection, Patient Controlled Analgesia, Optimizing Basal Infusion Mode
Eligibility Criteria
Inclusion Criteria:
- The subjects who undergoing colon resection due to colon cancer
- ASA class Ⅰ-Ⅲ
- Written consents obtained to participate voluntarily in this clinical trial
Exclusion Criteria:
- Sudden change of surgical plan
- Patients who have the hypersensitivity to the pain killers including narcotics
- Patients who are unable to express the degree of pain
Sites / Locations
- Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
1) Conventional PCA mode
2) Optimizing B.I PCA mode
Arm Description
(Mode setting; total volume: 140 ml, flow rate: 2 ml, bolus volume: 0.5 ml, and LOT: 15 minutes)
Optimizing Basal Infusion (New) PCA mode(Mode setting; total volume: 140 ml, flow rate: changable by patients' requirement, bolus volume: 0.5 ml, and LOT: 15 minutes)
Outcomes
Primary Outcome Measures
pain
At 6 hours after surgery, the pain scores will be measured by numeric rating scale range from 0 to 10.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03011359
Brief Title
The Comparison of Postoperative Pain After Colon Resection in Intravenous Patient-controlled Analgesia Between Conventional Mode and Optimizing B.I Mode With 'PAINSTOP' Equipment
Official Title
The Comparison of Postoperative Pain After Colon Resection in Intravenous
Study Type
Interventional
2. Study Status
Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
June 17, 2018 (Actual)
Primary Completion Date
December 7, 2018 (Actual)
Study Completion Date
December 7, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yonsei University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Colon resection is one of the major surgery, the postoperative pain is so severe that it is necessary to use additional analgesics as well as a patient controlled analgesia (PCA). The most common pain management of this surgery is the intravenous (IV) PCA. If it is relatively insufficient amount of narcotic analgesics ,in the case of IV PCA, may be failed to reduce the pain effectively. Consequently, it may result in the a lot of rescue analgesics use, which leads to the adverse effects in patients who are very sensitive to narcotic analgesics. And the patient's satisfaction to the PCA may be low.
For the recently released PCA instrument 'PAINSTOP', the investigators can specify the mode setting including total volume, flow rate (basal rate) per hour, bolus dose, and lock out time (LOT). Furthermore, this device can be set to optimize basal infusion (B.I), which is a new mode, so that the administered rate and amount of drug can be increased or decreased according to the patient's use of bolus button. Therefore, this PCA device can be implemented to the conventional mode, and added the function of automatically controlling the basal rate and administered amount of drug according to the use demand of the patient. However, since there are few studies related to this new mode of PCA, more research is needed in patients with postoperative pain.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colon Cancer
Keywords
Colon resection, Patient Controlled Analgesia, Optimizing Basal Infusion Mode
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
66 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1) Conventional PCA mode
Arm Type
Experimental
Arm Description
(Mode setting; total volume: 140 ml, flow rate: 2 ml, bolus volume: 0.5 ml, and LOT: 15 minutes)
Arm Title
2) Optimizing B.I PCA mode
Arm Type
Active Comparator
Arm Description
Optimizing Basal Infusion (New) PCA mode(Mode setting; total volume: 140 ml, flow rate: changable by patients' requirement, bolus volume: 0.5 ml, and LOT: 15 minutes)
Intervention Type
Other
Intervention Name(s)
Optimizing B.I (New) PCA mode
Other Intervention Name(s)
(Mode setting; total volume: 150 ml, flow rate: changable by patients' requirement, bolus volume: 0.5 ml, and LOT: 10 minutes)
Intervention Description
In the intervention group, the optimizing B.I PCA mode will be setted. This mode is setted that the amount of administered drug per hour will be increased by 0.3 ml by pressing bolus button (The interval: ~ 6 hr: 1.5 - 3.5 ml, 6-24 hr: 1 - 3 ml, 24 hr ~ : 0.5 - 2.5 ml). Conversely, if the bolus button is not used for 90 minutes, the administered amount of drug per hour is setted to be reduced by 0.1 ml, and the maximum (or minimum) allowable flow rate is 3.5 ml (or 0.5 ml).
Intervention Type
Other
Intervention Name(s)
Conventional PCA mode
Intervention Description
(Mode setting; total volume: 150 ml, flow rate: 2 ml, bolus volume: 0.5 ml, and LOT: 10 minutes)
Primary Outcome Measure Information:
Title
pain
Description
At 6 hours after surgery, the pain scores will be measured by numeric rating scale range from 0 to 10.
Time Frame
At postoperative 6 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
The subjects who undergoing colon resection due to colon cancer
ASA class Ⅰ-Ⅲ
Written consents obtained to participate voluntarily in this clinical trial
Exclusion Criteria:
Sudden change of surgical plan
Patients who have the hypersensitivity to the pain killers including narcotics
Patients who are unable to express the degree of pain
Facility Information:
Facility Name
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine
City
Seoul
Country
Korea, Republic of
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Comparison of Postoperative Pain After Colon Resection in Intravenous Patient-controlled Analgesia Between Conventional Mode and Optimizing B.I Mode With 'PAINSTOP' Equipment
We'll reach out to this number within 24 hrs